Pfeifer, M., Zheng, B., Erdmann, T., Koeppen, H., McCord, R., Grau, M., . . . Morschhauser, F. (2015). Anti-CD22 and anti-CD79B antibody drug conjugates are active in different molecular diffuse large B-cell lymphoma subtypes. Leukemia (08876924), 29(7), 1578. https://doi.org/10.1038/leu.2015.48
Chicago Style (17th ed.) CitationPfeifer, M., et al. "Anti-CD22 and Anti-CD79B Antibody Drug Conjugates Are Active in Different Molecular Diffuse Large B-cell Lymphoma Subtypes." Leukemia (08876924) 29, no. 7 (2015): 1578. https://doi.org/10.1038/leu.2015.48.
MLA (9th ed.) CitationPfeifer, M., et al. "Anti-CD22 and Anti-CD79B Antibody Drug Conjugates Are Active in Different Molecular Diffuse Large B-cell Lymphoma Subtypes." Leukemia (08876924), vol. 29, no. 7, 2015, p. 1578, https://doi.org/10.1038/leu.2015.48.